ABCLAbCellera BiologicsABCL info
$2.73info1.87%24h
Global rank8912
Market cap$792.16M
Change 7d-0.73%
YTD Performance-51.42%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    AbCellera Biologics (ABCL) Stock Overview

    AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company; and a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

    ABCL Stock Information

    Symbol
    ABCL
    Address
    2215 Yukon StreetVancouver, BC V5Y 0A1Canada
    Founded
    -
    Trading hours
    9:30 AM - 4:00 PM ET
    Website
    https://www.abcellera.com
    Country
    🇨🇦 Canada
    Phone Number
    604-559-9005

    AbCellera Biologics (ABCL) Price Chart

    -
    Value:-

    AbCellera Biologics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.73
    N/A
    Market Cap
    $792.16M
    N/A
    Shares Outstanding
    290.17M
    N/A
    Employees
    630.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org